Clinical Trials on Stage I Adult Non-Hodgkin Lymphoma in Norway
Total 83 results
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs Hospital; Norwegian Cancer SocietyActive, not recruitingChildhood Acute Lymphoblastic Leukemia | Childhood Acute Myeloid Leukemia | Childhood Non-Hodgkin LymphomaNorway
-
Biotec Pharmacon ASACompletedNon-Hodgkin's LymphomaNorway
-
Nordic NanovectorICON Clinical ResearchCompletedFollicular Lymphoma | Non Hodgkin Lymphoma | Relapsed Follicular LymphomaCzechia, Norway
-
MorphoSys AGCompletedNon-Hodgkin LymphomaUnited States, Belgium, Germany, Hungary, Italy, Poland, Spain
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
University of AarhusActive, not recruitingMalignant LymphomaNetherlands, Norway, Denmark, Finland, Sweden
-
Oslo University HospitalMerck Sharp & Dohme LLC; Norwegian Cancer SocietyCompleted
-
Oslo University HospitalNorwegian Cancer Society; Helse Sor-OstCompletedFollicular LymphomaNorway
-
Oslo University HospitalUniversity of OsloUnknown
-
Oslo University HospitalCompleted
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Nordic Lymphoma GroupActive, not recruitingRelapsed Non Hodgkin LymphomaNorway, Sweden, Finland, Denmark
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Oslo University HospitalAarhus University Hospital; Hoffmann-La RocheRecruitingLymphoma, FollicularNorway, Finland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
GenmabAbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, France, Italy, Spain, United Kingdom, Belgium, Denmark, Netherlands, Finland, Czechia, Sweden, Australia, Norway
-
BayerCompletedLymphoma, Non-HodgkinBelgium, France, Spain, Italy, Canada, Switzerland, Netherlands, United Kingdom, Portugal, Germany, Sweden, Denmark, Norway
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Australia, Brazil, Canada, Mexico, New Zealand, Peru
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and...Active, not recruiting
-
Nordic Lymphoma GroupAmgenCompletedDiffuse Large B-Cell LymphomaNorway, Denmark, Finland, Sweden
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingMature B-cell Non-Hodgkin LymphomaAustria, Czechia, Denmark, Finland, Germany, Norway, Sweden, Switzerland
-
Novartis PharmaceuticalsCompletedNon-Hodgkin LymphomaJapan, Spain, Germany, Australia, Austria, Canada, Italy, Norway, United States, United Kingdom, Finland, France, Denmark, Netherlands
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, Russian Federation, United Kingdom, Brazil, Ecuador, Germany, Slovenia, Spain, Norway, Switzerland, France, Hungary, Romania, Austria, Albania, Bulgaria, Slovakia, Sweden, Turkey, Argentina, Colombia, Greece, Egypt, Lithuania
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
St. Olavs HospitalOslo University Hospital; Norwegian University of Science and TechnologyCompletedCutaneous T-Cell Lymphoma, Unspecified | Chronic Graft Versus Host Disease in SkinNorway
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedLymphoma, Non-Hodgkin | Central Nervous System NeoplasmsNorway
-
University of AarhusNordic Lymphoma GroupCompletedPeripheral T-Cell LymphomaNorway, Finland, Denmark
-
European Organisation for Research and Treatment...NCIC Clinical Trials Group; Stichting Hemato-Oncologie voor Volwassenen Nederland and other collaboratorsCompletedLymphomaFrance, Netherlands, United Kingdom, Australia, Canada, Norway, Poland, Belgium, Italy, New Zealand, Denmark, Egypt, Hungary, Portugal, Slovakia, Slovenia, South Africa, Sweden
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
Nordic Lymphoma GroupHelsinki University Central Hospital; Aarhus University HospitalRecruitingLymphoma, Large B-Cell, DiffuseDenmark, Norway, Sweden, Finland
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Nordic Lymphoma GroupAstraZenecaActive, not recruitingMantle Cell Lymphoma | MCLFinland, Sweden, Norway, Denmark, Korea, Republic of
-
Swiss Group for Clinical Cancer ResearchNordic Lymphoma GroupTerminatedFollicular LymphomaSweden, Finland, Denmark, Norway, Switzerland, Austria
-
SanofiCompletedDiffuse Large B-Cell LymphomaNorway, Austria, France
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingLymphoblastic Lymphoma, ChildhoodSpain, Austria, Denmark, Finland, Germany, Belgium, Switzerland, China, Czechia, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden
-
Novartis PharmaceuticalsActive, not recruitingFollicular LymphomaUnited States, Spain, Belgium, Japan, Australia, Germany, Italy, Netherlands, Norway, United Kingdom, Austria, France
-
Bristol-Myers SquibbCompletedLymphomaAustralia, Italy, United States, Spain, Canada, United Kingdom, Germany, Belgium, France, Singapore, Sweden, Norway
-
International Extranodal Lymphoma Study Group (IELSG)RecruitingSplenic Marginal Zone LymphomaSpain, Denmark, France, Norway, Switzerland, Sweden, Italy
-
Aarhus University HospitalGCP-unit at Aarhus University Hospital, Aarhus, DenmarkCompletedLymphoma, T-Cell, PeripheralNorway, Belgium, Finland, Denmark, Austria, Czechia, Portugal, Germany, Netherlands, Poland, Sweden
-
Haukeland University HospitalKarolinska University Hospital; Oslo University Hospital; University Hospital... and other collaboratorsRecruitingSeminoma | Testicular Germ Cell Cancer | Non-Seminoma Testicular Cancer | Stage I Testicular Cancer | Stage II Testicular Cancer | Stage III Testicular Cancer | Stage IV Testicular Cancer | Relapse Testicular CancerNorway, Sweden
-
Hoffmann-La RocheCompletedLymphoma, FollicularSpain, Sweden, Canada, Mexico, Czech Republic, France, Switzerland, Australia, Israel, Korea, Republic of, United Kingdom, Italy, Brazil, Finland, Russian Federation, Peru, Denmark, Argentina, Poland, Ecuador, Norway, Slovakia
-
Chiron CorporationCompletedLymphoma, Non-HodgkinUnited States
-
Prof. Dr. M. Dreyling (co-chairman)LMU KlinikumRecruitingMantle Cell LymphomaGermany, Sweden, Denmark, Italy, Norway
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingPrimary Mediastinal B-cell LymphomaNorway, United Kingdom, Italy, Switzerland, Czechia, United States, China, Argentina, Canada, Germany, Poland, Portugal, Sweden, Ukraine